APA citiranje

Sakhdari, A., Thakral, B., Loghavi, S., Kanagal‐Shamanna, R., Yin, C. C., Zuo, Z., . . . Ok, C. Y. (2019). RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD. Cancer Med.

Citação norma Chicago

Sakhdari, Ali, et al. "RAS and TP53 Can Predict Survival in Adults With T‐cell Lymphoblastic Leukemia Treated With Hyper‐CVAD." Cancer Med 2019.

MLA citiranje

Sakhdari, Ali, et al. "RAS and TP53 Can Predict Survival in Adults With T‐cell Lymphoblastic Leukemia Treated With Hyper‐CVAD." Cancer Med 2019.